Clinical Trials Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaABC008 in Subjects With T-cell Large Granular Lymphocytic Leukemia (T-LGLL)A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
